UCA1 and cancer: Aberrantly high expression of the lncRNA UCA1 has been reported in NSCLC, and UCA1 interference upregulated miR-185-5p to inhibit downstream β-catenin/TCF-4 activity, subsequently decreased Beclin-1 and LC3-II levels and enhanced p62 expression, thereby reducing autophagy in NSCLC cells and attenuating cancer proliferation [81].